GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aligned Genetics Inc (XKRX:238120) » Definitions » EV-to-Revenue

Aligned Genetics (XKRX:238120) EV-to-Revenue : 3.22 (As of May. 31, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Aligned Genetics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Aligned Genetics's enterprise value is ₩48,230 Mil. Aligned Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩14,990 Mil. Therefore, Aligned Genetics's EV-to-Revenue for today is 3.22.

The historical rank and industry rank for Aligned Genetics's EV-to-Revenue or its related term are showing as below:

XKRX:238120' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.09   Med: 5.13   Max: 13.19
Current: 3.21

During the past 10 years, the highest EV-to-Revenue of Aligned Genetics was 13.19. The lowest was -2.09. And the median was 5.13.

XKRX:238120's EV-to-Revenue is ranked better than
52.11% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: 3.17 vs XKRX:238120: 3.21

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-31), Aligned Genetics's stock price is ₩4130.00. Aligned Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,044.24. Therefore, Aligned Genetics's PS Ratio for today is 3.96.


Aligned Genetics EV-to-Revenue Historical Data

The historical data trend for Aligned Genetics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aligned Genetics EV-to-Revenue Chart

Aligned Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.63 7.56 4.50 3.26 3.13

Aligned Genetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 3.92 3.50 3.13 3.60

Competitive Comparison of Aligned Genetics's EV-to-Revenue

For the Medical Devices subindustry, Aligned Genetics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aligned Genetics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aligned Genetics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aligned Genetics's EV-to-Revenue falls into.



Aligned Genetics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Aligned Genetics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=48230.384/14990.467
=3.22

Aligned Genetics's current Enterprise Value is ₩48,230 Mil.
Aligned Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩14,990 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aligned Genetics  (XKRX:238120) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Aligned Genetics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4130.00/1044.238
=3.96

Aligned Genetics's share price for today is ₩4130.00.
Aligned Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,044.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aligned Genetics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aligned Genetics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aligned Genetics (XKRX:238120) Business Description

Traded in Other Exchanges
N/A
Address
28 Simindaero 327 beon-gil, Floor 2nd and 3rd, Dongan-gu Anyang-si, Gyeonggi-do, KOR, 14055
Aligned Genetics Inc is engaged in developing automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

Aligned Genetics (XKRX:238120) Headlines

No Headlines